368 related articles for article (PubMed ID: 7682911)
1. Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy.
Palmer KJ; Holliday SM; Brogden RN
Drugs; 1993 Mar; 45(3):430-75. PubMed ID: 7682911
[TBL] [Abstract][Full Text] [Related]
2. Halofantrine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic potential.
Bryson HM; Goa KL
Drugs; 1992 Feb; 43(2):236-58. PubMed ID: 1372221
[TBL] [Abstract][Full Text] [Related]
3. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
McKeage K; Scott L
Drugs; 2003; 63(6):597-623. PubMed ID: 12656656
[TBL] [Abstract][Full Text] [Related]
4. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of artesunate and artemether in combination with mefloquine on multidrug resistant falciparum malaria in eastern Thailand.
Thimasarn K; Sirichaisinthop J; Chanyakhun P; Palananth C; Rooney W
Southeast Asian J Trop Med Public Health; 1997 Sep; 28(3):465-71. PubMed ID: 9561593
[TBL] [Abstract][Full Text] [Related]
6. Clinical application of mefloquine pharmacokinetics in the treatment of P falciparum malaria.
Karbwang J; Na-Bangchang K
Fundam Clin Pharmacol; 1994; 8(6):491-502. PubMed ID: 7721226
[TBL] [Abstract][Full Text] [Related]
7. Antimalarial drug toxicity: a review.
Taylor WR; White NJ
Drug Saf; 2004; 27(1):25-61. PubMed ID: 14720085
[TBL] [Abstract][Full Text] [Related]
8. Mefloquine--its 20 years in the Thai Malaria Control Program.
Wongsrichanalai C; Prajakwong S; Meshnick SR; Shanks GD; Thimasarn K
Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):300-8. PubMed ID: 15691128
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of atovaquone-proguanil compared with mefloquine in the treatment of nonimmune patients with uncomplicated P. falciparum malaria in Japan.
Hitani A; Nakamura T; Ohtomo H; Nawa Y; Kimura M
J Infect Chemother; 2006 Oct; 12(5):277-82. PubMed ID: 17109092
[TBL] [Abstract][Full Text] [Related]
10. Response of falciparum malaria to different antimalarials in Myanmar.
Ejov MN; Tun T; Aung S; Sein K
Bull World Health Organ; 1999; 77(3):244-9. PubMed ID: 10212515
[TBL] [Abstract][Full Text] [Related]
11. Comparison of mefloquine, chloroquine plus pyrimethamine-sulfadoxine (Fansidar), and chloroquine as malarial prophylaxis in eastern Thailand.
Boudreau EF; Pang LW; Chaikummao S; Witayarut C
Southeast Asian J Trop Med Public Health; 1991 Jun; 22(2):183-9. PubMed ID: 1948277
[TBL] [Abstract][Full Text] [Related]
12. Six-years monitoring the efficacy of the combination of artesunate and mefloquine for the treatment of uncomplicated falciparum malaria.
Wattanakoon Y; Chittamas S; Pornkulprasit V; Kanda T; Thimasarn K; Rojanawatsirivej C; Looareesuwan S; Bunnag D
Southeast Asian J Trop Med Public Health; 2003 Sep; 34(3):542-5. PubMed ID: 15115124
[TBL] [Abstract][Full Text] [Related]
13. In vivo study of the response of Plasmodium falciparum to standard mefloquine/sulfadoxine/pyrimethamine (MSP) treatment among gem miners returning from Cambodia.
Thimasarn K; Sirichaisinthop J; Vijaykadga S; Tansophalaks S; Yamokgul P; Laomiphol A; Palananth C; Thamewat U; Tháithong S; Rooney W
Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):204-12. PubMed ID: 8629047
[TBL] [Abstract][Full Text] [Related]
14. High-dose mefloquine in the treatment of multidrug-resistant falciparum malaria.
ter Kuile FO; Nosten F; Thieren M; Luxemburger C; Edstein MD; Chongsuphajaisiddhi T; Phaipun L; Webster HK; White NJ
J Infect Dis; 1992 Dec; 166(6):1393-400. PubMed ID: 1431257
[TBL] [Abstract][Full Text] [Related]
15. Artesunate. A review of its pharmacology and therapeutic efficacy in the treatment of malaria.
Barradell LB; Fitton A
Drugs; 1995 Oct; 50(4):714-41. PubMed ID: 8536555
[TBL] [Abstract][Full Text] [Related]
16. Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
Smithuis F; Shahmanesh M; Kyaw MK; Savran O; Lwin S; White NJ
Trop Med Int Health; 2004 Nov; 9(11):1184-90. PubMed ID: 15548314
[TBL] [Abstract][Full Text] [Related]
17. Malaria Surveillance - United States, 2015.
Mace KE; Arguin PM; Tan KR
MMWR Surveill Summ; 2018 May; 67(7):1-28. PubMed ID: 29723168
[TBL] [Abstract][Full Text] [Related]
18. UK malaria treatment guidelines.
Lalloo DG; Shingadia D; Pasvol G; Chiodini PL; Whitty CJ; Beeching NJ; Hill DR; Warrell DA; Bannister BA;
J Infect; 2007 Feb; 54(2):111-21. PubMed ID: 17215045
[TBL] [Abstract][Full Text] [Related]
19. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
Gosling RD; Gesase S; Mosha JF; Carneiro I; Hashim R; Lemnge M; Mosha FW; Greenwood B; Chandramohan D
Lancet; 2009 Oct; 374(9700):1521-32. PubMed ID: 19765815
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of chloroquine, sulfadoxine-pyrimethamine, and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria on the north coast of Peru.
Marquiño W; MacArthur JR; Barat LM; Oblitas FE; Arrunátegui M; Garavito G; Chafloque ML; Pardavé B; Gutierrez S; Arróspide N; Carrillo C; Cabezas C; Ruebush TK
Am J Trop Med Hyg; 2003 Jan; 68(1):120-3. PubMed ID: 12557836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
